299 related articles for article (PubMed ID: 26933913)
1. Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma.
Shi H; Chen J; Li Y; Li G; Zhong R; Du D; Meng R; Kong W; Lu M
Oncotarget; 2016 Apr; 7(16):21579-90. PubMed ID: 26933913
[TBL] [Abstract][Full Text] [Related]
2. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
[TBL] [Abstract][Full Text] [Related]
3. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
Gao X; Wu Y; Yu W; Li H
Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
[TBL] [Abstract][Full Text] [Related]
4. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients.
Huang Y; Liu Z; Zhong L; Wen Y; Ye Q; Cao D; Li P; Liu Y
BMC Genomics; 2020 Oct; 21(1):691. PubMed ID: 33023466
[TBL] [Abstract][Full Text] [Related]
5. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
6. Six-MicroRNA Prognostic Signature in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma.
Worakitchanon W; Panvongsa W; Siripoon T; Kitdumrongthum S; Wongpan A; Arsa L; Trachu N; Jinawath N; Chairoungdua A; Ngamphaiboon N
JCO Precis Oncol; 2023 May; 7():e2300003. PubMed ID: 37163716
[TBL] [Abstract][Full Text] [Related]
7. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
Zhao X; Cui L
J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
[TBL] [Abstract][Full Text] [Related]
8. A seven-gene prognostic signature for rapid determination of head and neck squamous cell carcinoma survival.
Shen S; Bai J; Wei Y; Wang G; Li Q; Zhang R; Duan W; Yang S; Du M; Zhao Y; Christiani DC; Chen F
Oncol Rep; 2017 Dec; 38(6):3403-3411. PubMed ID: 29130107
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a five-microRNA signature as a prognostic biomarker for esophageal squamous cell carcinoma.
Yu J; Zhu M; Lv M; Wu X; Zhang X; Zhang Y; Li J; Zhang Q
Sci Rep; 2019 Dec; 9(1):19847. PubMed ID: 31882677
[TBL] [Abstract][Full Text] [Related]
10. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
Liu C; Yu Z; Huang S; Zhao Q; Sun Z; Fletcher C; Jiang Y; Zhang D
EBioMedicine; 2019 Dec; 50():135-143. PubMed ID: 31780396
[TBL] [Abstract][Full Text] [Related]
11. An 11-lncRNA expression could be potential prognostic biomarkers in head and neck squamous cell carcinoma.
Xu Q; Yin H; Ao H; Leng X; Liu M; Liu Y; Ma J; Wang X
J Cell Biochem; 2019 Oct; 120(10):18094-18103. PubMed ID: 31144382
[TBL] [Abstract][Full Text] [Related]
12. A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C
Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
[TBL] [Abstract][Full Text] [Related]
14. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
Gene; 2019 May; 697():86-93. PubMed ID: 30779946
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
16. A novel microRNA signature predicts survival in stomach adenocarcinoma.
Ding B; Gao X; Li H; Liu L; Hao X
Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.
Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X
Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411
[TBL] [Abstract][Full Text] [Related]
18. Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset.
Wu C; Tong L; Wu C; Chen D; Chen J; Li Q; Jia F; Huang Z
Cancer Med; 2020 Apr; 9(8):2631-2642. PubMed ID: 32064753
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.
Hou B; Ishinaga H; Midorikawa K; Shah SA; Nakamura S; Hiraku Y; Oikawa S; Murata M; Takeuchi K
Cancer Biol Ther; 2015; 16(7):1042-6. PubMed ID: 25950115
[TBL] [Abstract][Full Text] [Related]
20. Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients.
Kostareli E; Hielscher T; Zucknick M; Baboci L; Wichmann G; Holzinger D; Mücke O; Pawlita M; Del Mistro A; Boscolo-Rizzo P; Da Mosto MC; Tirelli G; Plinkert P; Dietz A; Plass C; Weichenhan D; Hess J
Epigenetics; 2016; 11(1):61-73. PubMed ID: 26786582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]